33 Results for "

NCoR

" in MedChemExpress (MCE) Product Catalog:
Products (33)

33 Results for "NCoR" in MCE Product Catalog:

11
11 Cited Publications
Cat. No.: HY-114421
CAS No.: 2064175-41-1
Purity:  99.89%
Synonyms: dTAG-13
Research Areas:  

Cancer

FKBP12 PROTAC dTAG-13 (dTAG-13) is a FKBP12 F36V PROTAC degrader and a PXR partial agonist. FKBP12 PROTAC dTAG-13 induces ubiquitination and proteasomal degradation of proteins tagged with FKBP12 F36V, without degrading wild-type FKBP12 or un-fused PXR. It weakly promotes the recruitment of SRC-1, strongly inhibits the interaction between NCoR and PXR, and upregulates the expression of CYP3A4 and other drug metabolism-related genes. FKBP12 PROTAC dTAG-13 is applicable to research related to breast cancer and leukemia [1] .
loading...
    loading...
Cat. No.: HY-176851
CAS No.: 2986733-57-5
Target:  

REV-ERB

Research Areas:  

Inflammation/Immunology

GSK1362 is a selective inverse agonist of REV-ERB. GSK1362disrupts the interaction of REV-ERBα with repressive co-modulators (NCoR1, SMRT2, RIP140). GSK1362 exerts an inverse agonist effect by increasing the transcription of BMAL1 to relieve BMAL1 repression by endogenous REV-ERB ligands. GSK1362 suppresses LPS (HY-D1056)-induced inflammatory cytokine expression, inhibits IL-1β-induced Cxcl5 transcription in cells. GSK1362 can be used for the study of inflammatory diseases .
loading...
    loading...
Cat. No.: HY-112247
CAS No.: 2088135-12-8
Purity:  99.89%
SR 16832 is a dual-site covalent, orthosteric and allosteric PPARγ antagonist. SR 16832 activates the TGF-β signaling pathway and upregulates the expression of Vimentin and Fibronectin (Fibronectin). SR 16832 is toxic to bronchial epithelium. SR 16832 can be used in research related to type 2 diabetes and pulmonary fibrosis .
loading...
    loading...
Cat. No.: HY-121900
CAS No.: 862901-87-9
Purity:  99.79%
Target:  

PPAR

Research Areas:  

Metabolic Disease Endocrinology

LT175, a dual PPARα/γ ligand, is an orally active partial agonist against PPARγ(hPPARα:EC50=0.22 μm; mPPARα:EC50=0.26 μm; hPPARγ:EC50=0.48 μm). LT175 interacts with PPARγ and affects the recruitment of the coregulators cyclic-AMP response element-binding protein-binding protein and nuclear corepressor 1 (NCoR1). LT175 interacts with PPARγ in a hydrophobic region called “diphenyl pocket”. LT175 has potent insulin-sensitizing effects and reduced adipogenic properties .
loading...
    loading...
Cat. No.: HY-RS09096
Research Areas:  

Others

NCOR1 Human Pre-designed siRNA Set A contains three designed siRNAs for NCOR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-106058
CAS No.: 84518-80-9
Target:  

Cathepsin Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

NCO-700 is a dual cathepsin B and calcium-activated neutral protease (CANP) inhibitor with IC50 values of 0.8 and 46 μM, respectively. NCO-700 reduces the degradation of myocardial fibrin by inhibiting protease activity. NCO-700 also has inhibitory effects on hormone-independent tumor cells, such as prostate cancer cells, and induces apoptosis. NCO-700 can be used to study myocardial ischemia and refractory hormone-independent tumors .
loading...
    loading...
Cat. No.: HY-RS20452
Research Areas:  

Others

Ncor1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ncor1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-177756
CAS No.: 2230406-60-5
Target:  

BCL6

Research Areas:  

Cancer

BCL6-IN-11 (Compound 8) is an efficient inhibitor that induces partial degradation of BCL6 with its IC50 value for inhibiting the interaction between BCL6 and its co-inhibitory proteins (such as NCOR1) of 6 nM. BCL6-IN-11 can induce approximately 52% degradation of BCL6 after being treated with 5 μM concentration for 90 minutes, and thus is also classified as a partial degrader. BCL6-IN-11 can be used for the study of lymphoma .
loading...
    loading...
Cat. No.: HY-173033
CAS No.: 2530027-71-3
MI-883 is orally active constitutive androstane receptor (CAR) (EC50 of 73 nM) agonist and pregnane X Receptor (PXR) (IC50 of 100 nM) antagonist. MI-883 binds to CAR and PXR ligand-binding domains, promotes CAR LBD assembly, activates CAR3 variant, stimulates CAR cytoplasmic-nuclear translocation, upregulates CAR target genes, recruits coactivators NCOA1, NCOA2, NCOA3, inhibits basal and agonist-induced PXR activation, downregulates PXR target genes, disrupts PXR-NCOR2 interaction, blocks agonist-mediated PXR-NCOA1 recruitment. MI-883 reduces plasma total cholesterol, LDL cholesterol, and hepatic free cholesterol levels, increases fecal bile acid excretion, regulates genes involved in xenobiotic metabolism, cholesterol homeostasis, and bile acid homeostasis. MI-883 exhibits metabolic stability, liver-predominant distribution, a safety profile with no observed toxicity, and does not stimulate human hepatocyte hypertrophy or hyperplasia. MI-883 can be used for the research of diet-induced hypercholesterolemia .
loading...
    loading...
Cat. No.: HY-RS09097
Research Areas:  

Others

NCOR2 Human Pre-designed siRNA Set A contains three designed siRNAs for NCOR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS26961
Research Areas:  

Others

Ncor1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ncor1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19464
Research Areas:  

Others

Ncor2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Ncor2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-110134
CAS No.: 883226-64-0
Research Areas:  

Metabolic Disease

S07662 is a human constitutive androstane receptor (hCAR) inhibitor with an IC50 of 0.7 μM. S07662 recruits the corepressor NCoR in cell-based assays and attenuate the expression of CYP2B6 mRNA in human primary hepatocytes induced by phenytoin (HY-B0448) and CITCO (HY-103244) .
loading...
    loading...
Cat. No.: HY-RS25957
Research Areas:  

Others

Ncor2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Ncor2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P83859
Synonyms: N-CoR; TRAC1; hN-CoR

Host:  

Mouse

Application:  

IHC-P, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P83859A
Synonyms: N-CoR; TRAC1; hN-CoR

Host:  

Mouse

Application:  

IHC-P, ELISA

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-185682
CAS No.: 1382354-26-8
Research Areas:  

Cancer

NCO-141 is a selective SIRT2 inhibitor with an IC50 of 0.5 μM. NCO-141 induces cell apoptosis via caspase activation and mitochondrial superoxide anion production. NCO-141 induces cell autophagy by increasing LC3-II levels and autophagosome accumulation. NCO-141 is applicable to relevant research on leukemia .
loading...
    loading...
Cat. No.: HY-106058A
CAS No.: 84579-82-8
Target:  

Cathepsin Apoptosis

Research Areas:  

Cancer

NCO-700 sulfate is a dual cathepsin B and calcium-activated neutral protease (CANP) inhibitor with IC50 values of 0.8 and 46 μM, respectively. NCO-700 sulfate reduces the degradation of myocardial fibrin by inhibiting protease activity. NCO-700 sulfate also has inhibitory effects on hormone-independent tumor cells, such as prostate cancer cells, and induces apoptosis. NCO-700 sulfate can be used to study myocardial ischemia and refractory hormone-independent tumors .
loading...
    loading...
Cat. No.: HY-183870
CAS No.: 1382354-18-8
NCO-90 is a selective SIRT2 inhibitor with an IC50 of 1.0 μM. NCO-90 induces Apoptosis via Caspase activation and mitochondrial superoxide anion production, and also induces Autophagic cell death by increasing LC3-II levels and autophagosome accumulation. NCO-90 exhibits anticancer activity against leukemia. NCO-90 can be used in research related to acute lymphoblastic leukemia and acute myeloid leukemia .
loading...
    loading...
Cat. No.: HY-182414
CAS No.: 81907-78-0
Target:  

Ser/Thr Protease

Research Areas:  

Inflammation/Immunology

NCO-650 free base is an antiallergic agent that acts by inhibiting tryptase, a key trypsin-like protease in mast cells. NCO-650 free base inhibits mast cell histamine release, increases intracellular cAMP levels in mast cells, suppresses bronchoconstriction, and prevents decreases in perfusion pressure and systemic blood pressure. NCO-650 free base is applicable to the research of allergic diseases and bronchial asthma .
loading...
    loading...